As the nodal body ICMR (Indian Council of Medical Research) supported indigenous vaccine moves a step closer to success, nodal officer of the trials of the Bharat Biotech's COVAXIN speaks to NDTV and explains how the results of the first phase of the clinical trials have been encouraging.